These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31105706)

  • 1.
    Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho SN
    Front Immunol; 2019; 10():896. PubMed ID: 31105706
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
    Smith SG; Zelmer A; Blitz R; Fletcher HA; Dockrell HM
    Vaccine; 2016 Oct; 34(44):5298-5305. PubMed ID: 27622301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans:
    Tanner R; Satti I; Harris SA; O'Shea MK; Cizmeci D; O'Connor D; Chomka A; Matsumiya M; Wittenberg R; Minassian AM; Meyer J; Fletcher HA; McShane H
    Front Immunol; 2019; 10():2983. PubMed ID: 31998295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.
    Lule SA; Mawa PA; Nkurunungi G; Nampijja M; Kizito D; Akello F; Muhangi L; Elliott AM; Webb EL
    Vaccine; 2015 Feb; 33(6):796-804. PubMed ID: 25529292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
    Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
    Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4
    Boillat-Blanco N; Tumbo AN; Perreau M; Amelio P; Ramaiya KL; Mganga M; Schindler C; Gagneux S; Reither K; Probst-Hensch N; Pantaleo G; Daubenberger C; Portevin D
    Immun Inflamm Dis; 2018 Jun; 6(2):345-353. PubMed ID: 29642283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans.
    Prabowo SA; Smith SG; Seifert K; Fletcher HA
    Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterial growth inhibition is associated with trained innate immunity.
    Joosten SA; van Meijgaarden KE; Arend SM; Prins C; Oftung F; Korsvold GE; Kik SV; Arts RJ; van Crevel R; Netea MG; Ottenhoff TH
    J Clin Invest; 2018 May; 128(5):1837-1851. PubMed ID: 29461976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells.
    Prabowo SA; Zelmer A; Stockdale L; Ojha U; Smith SG; Seifert K; Fletcher HA
    Sci Rep; 2019 Mar; 9(1):4842. PubMed ID: 30890730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
    Walsh DS; Owira V; Polhemus M; Otieno L; Andagalu B; Ogutu B; Waitumbi J; Hawkridge A; Shepherd B; Pau MG; Sadoff J; Douoguih M; McClain JB;
    Vaccine; 2016 May; 34(21):2430-2436. PubMed ID: 27026148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.
    Brennan MJ; Tanner R; Morris S; Scriba TJ; Achkar JM; Zelmer A; Hokey DA; Izzo A; Sharpe S; Williams A; Penn-Nicholson A; Erasmus M; Stylianou E; Hoft DF; McShane H; Fletcher HA
    Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28701467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - Possible subunit vaccine candidates.
    Santhi D; Raja A
    J Infect; 2016 Nov; 73(5):455-467. PubMed ID: 27404979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
    Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
    Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Latent
    Lubyayi L; Mawa PA; Nabakooza G; Nakibuule M; Tushabe JV; Serubanja J; Aibo D; Akurut H; Tumusiime J; Hasso-Agopsowicz M; Kaleebu P; Levin J; Dockrell HM; Smith S; Webb EL; Elliott AM; Cose S
    Front Immunol; 2020; 11():929. PubMed ID: 32477371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.